Global GABA Receptor Agonists Supply, Demand and Key Producers, 2026-2032
The global GABA Receptor Agonists market size is expected to reach $ 7851 million by 2032, rising at a market growth of 7.2% CAGR during the forecast period (2026-2032).
GABA receptor agonists are prescription drugs and clinical formulations that target gamma-aminobutyric acid receptors in the central nervous system and either directly activate the receptors or, under a broader commercial market scope, enhance receptor-mediated inhibitory neurotransmission. They are not a single physical product form, but pharmaceutical products composed of active pharmaceutical ingredients, excipients, packaging materials, and delivery systems. Typical forms include white to off-white crystalline active ingredients, tablets, capsules, granules, oral suspensions, orally disintegrating tablets, injections, and lyophilized powders for injection. By receptor and pharmacological mechanism, they can be divided into GABA_A receptor-targeted drugs, GABA_B receptor-targeted drugs, partial agonists, positive allosteric modulators, and other GABAergic receptor-related drugs. Key technical requirements include stereochemical or polymorph control, impurity profiling, residual solvent control, immediate-release or sustained-release formulation design, aseptic filling, controlled-substance compliance, stability validation, and clinical therapeutic-window assessment. Their mechanism is to enhance inhibitory neurotransmission mediated by chloride channels or G-protein-coupled signaling, reduce neuronal excitability, and support treatment in spasticity, epilepsy, insomnia, procedural sedation and anesthesia, and selected rare neurological disorders.
Market development opportunities are mainly driven by long-term therapeutic demand in neurological and psychiatric disorders. Population aging, high prevalence of sleep disorders, a stable patient base in epilepsy and spasticity, increasing procedural sedation needs, and the approval of therapies for rare neurodevelopmental disorders are moving this category beyond mature low-priced generics toward specialty, pediatric, orphan-drug, and differentiated formulation markets. The strongest opportunities are expected in receptor subtype selectivity, partial agonism, short-acting and controllable pharmacology, lower residual sedation, reduced dependence potential, and dosage forms better suited for special populations.
The main market challenges are safety, abuse liability, and regulatory control. Traditional sedative-hypnotic and anxiolytic drugs are associated with somnolence, cognitive impairment, fall risk, respiratory depression, tolerance, physical dependence, and withdrawal or rebound effects. Several products are controlled substances, which raises compliance requirements for prescribing, manufacturing, distribution, and pharmacovigilance. Mature molecules face intense generic competition and persistent price erosion, while innovative drugs must prove clinical endpoints, long-term safety, reimbursement value, and differentiation against orexin receptor antagonists and newer non-GABA mechanisms in epilepsy and sleep medicine.
Downstream demand is shifting from broad sedation and empirical use toward more precise indication-based management. Hospitals increasingly value controllability, rapid onset and offset, and convenient administration in anesthesia, intensive care, epilepsy, and spasticity treatment. Retail and outpatient channels are focusing on standardized short-course use for insomnia and anxiety-related symptoms. Specialty demand is expanding into pediatric rare epilepsy, neurodevelopmental disorders, elderly patients, and patients with multiple comorbidities. Future growth is therefore unlikely to come from unrestricted prescription expansion; it will mainly come from safer products, clearer indications, better formulations, and substitution of older agents with improved therapeutic profiles.
This report studies the global GABA Receptor Agonists production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for GABA Receptor Agonists and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of GABA Receptor Agonists that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global GABA Receptor Agonists total production and demand, 2021-2032, (K Dose)
Global GABA Receptor Agonists total production value, 2021-2032, (USD Million)
Global GABA Receptor Agonists production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global GABA Receptor Agonists consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: GABA Receptor Agonists domestic production, consumption, key domestic manufacturers and share
Global GABA Receptor Agonists production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global GABA Receptor Agonists production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global GABA Receptor Agonists production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global GABA Receptor Agonists market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Roche, Novartis, Viatris, Teva Pharmaceutical Industries, Sandoz, Lundbeck, Biocodex, Immedica Pharma, Azurity Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World GABA Receptor Agonists market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (USD/Pcs) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global GABA Receptor Agonists Market, By Region:
1. How big is the global GABA Receptor Agonists market?
2. What is the demand of the global GABA Receptor Agonists market?
3. What is the year over year growth of the global GABA Receptor Agonists market?
4. What is the production and production value of the global GABA Receptor Agonists market?
5. Who are the key producers in the global GABA Receptor Agonists market?
6. What are the growth factors driving the market demand?
GABA receptor agonists are prescription drugs and clinical formulations that target gamma-aminobutyric acid receptors in the central nervous system and either directly activate the receptors or, under a broader commercial market scope, enhance receptor-mediated inhibitory neurotransmission. They are not a single physical product form, but pharmaceutical products composed of active pharmaceutical ingredients, excipients, packaging materials, and delivery systems. Typical forms include white to off-white crystalline active ingredients, tablets, capsules, granules, oral suspensions, orally disintegrating tablets, injections, and lyophilized powders for injection. By receptor and pharmacological mechanism, they can be divided into GABA_A receptor-targeted drugs, GABA_B receptor-targeted drugs, partial agonists, positive allosteric modulators, and other GABAergic receptor-related drugs. Key technical requirements include stereochemical or polymorph control, impurity profiling, residual solvent control, immediate-release or sustained-release formulation design, aseptic filling, controlled-substance compliance, stability validation, and clinical therapeutic-window assessment. Their mechanism is to enhance inhibitory neurotransmission mediated by chloride channels or G-protein-coupled signaling, reduce neuronal excitability, and support treatment in spasticity, epilepsy, insomnia, procedural sedation and anesthesia, and selected rare neurological disorders.
Market development opportunities are mainly driven by long-term therapeutic demand in neurological and psychiatric disorders. Population aging, high prevalence of sleep disorders, a stable patient base in epilepsy and spasticity, increasing procedural sedation needs, and the approval of therapies for rare neurodevelopmental disorders are moving this category beyond mature low-priced generics toward specialty, pediatric, orphan-drug, and differentiated formulation markets. The strongest opportunities are expected in receptor subtype selectivity, partial agonism, short-acting and controllable pharmacology, lower residual sedation, reduced dependence potential, and dosage forms better suited for special populations.
The main market challenges are safety, abuse liability, and regulatory control. Traditional sedative-hypnotic and anxiolytic drugs are associated with somnolence, cognitive impairment, fall risk, respiratory depression, tolerance, physical dependence, and withdrawal or rebound effects. Several products are controlled substances, which raises compliance requirements for prescribing, manufacturing, distribution, and pharmacovigilance. Mature molecules face intense generic competition and persistent price erosion, while innovative drugs must prove clinical endpoints, long-term safety, reimbursement value, and differentiation against orexin receptor antagonists and newer non-GABA mechanisms in epilepsy and sleep medicine.
Downstream demand is shifting from broad sedation and empirical use toward more precise indication-based management. Hospitals increasingly value controllability, rapid onset and offset, and convenient administration in anesthesia, intensive care, epilepsy, and spasticity treatment. Retail and outpatient channels are focusing on standardized short-course use for insomnia and anxiety-related symptoms. Specialty demand is expanding into pediatric rare epilepsy, neurodevelopmental disorders, elderly patients, and patients with multiple comorbidities. Future growth is therefore unlikely to come from unrestricted prescription expansion; it will mainly come from safer products, clearer indications, better formulations, and substitution of older agents with improved therapeutic profiles.
This report studies the global GABA Receptor Agonists production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for GABA Receptor Agonists and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of GABA Receptor Agonists that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global GABA Receptor Agonists total production and demand, 2021-2032, (K Dose)
Global GABA Receptor Agonists total production value, 2021-2032, (USD Million)
Global GABA Receptor Agonists production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global GABA Receptor Agonists consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: GABA Receptor Agonists domestic production, consumption, key domestic manufacturers and share
Global GABA Receptor Agonists production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global GABA Receptor Agonists production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global GABA Receptor Agonists production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global GABA Receptor Agonists market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Roche, Novartis, Viatris, Teva Pharmaceutical Industries, Sandoz, Lundbeck, Biocodex, Immedica Pharma, Azurity Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World GABA Receptor Agonists market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (USD/Pcs) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global GABA Receptor Agonists Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- GABA_A receptor-targeted drugs
- GABA_B receptor-targeted drugs
- Others
- Direct GABA receptor agonists
- Positive allosteric modulators
- Others
- Oral dosage forms
- Injectable dosage forms
- Others
- Attention Deficit Hyperactivity Disorder (ADHD)
- Psychiatric Disorders and Depression
- Alzheimer
- Epilepsy and Seizure
- Anxiety and Sleep Disorders
- Obesity and Alcoholism
- Sanofi
- Roche
- Novartis
- Viatris
- Teva Pharmaceutical Industries
- Sandoz
- Lundbeck
- Biocodex
- Immedica Pharma
- Azurity Pharmaceuticals
- Amneal Pharmaceuticals
- Fresenius Kabi
- Hikma Pharmaceuticals
- Eagle Pharmaceuticals
- PAION Pharma
- Mundipharma
- Eisai
- Sumitomo Pharma
- ANI Pharmaceuticals
- Zydus Lifesciences
- Aurobindo Pharma
- Sun Pharmaceutical Industries
- Cipla
- Torrent Pharmaceuticals
- Endo
- Baxter
- Hameln Pharma
- Ethypharm
- Neuraxpharm
- Sawai Pharmaceutical
- Towa Pharmaceutical
- Nichi-Iko Pharmaceutical
- Zhejiang Jingxin Pharmaceutical
- Jiangsu Nhwa Pharmaceutical
- Yichang Humanwell Pharmaceutical
- Shandong Sine Pharmaceutical
- Shanghai SPH Sine Pharmaceutical
1. How big is the global GABA Receptor Agonists market?
2. What is the demand of the global GABA Receptor Agonists market?
3. What is the year over year growth of the global GABA Receptor Agonists market?
4. What is the production and production value of the global GABA Receptor Agonists market?
5. Who are the key producers in the global GABA Receptor Agonists market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 GABA Receptor Agonists Introduction
1.2 World GABA Receptor Agonists Supply & Forecast
1.2.1 World GABA Receptor Agonists Production Value (2021 & 2025 & 2032)
1.2.2 World GABA Receptor Agonists Production (2021-2032)
1.2.3 World GABA Receptor Agonists Pricing Trends (2021-2032)
1.3 World GABA Receptor Agonists Production by Region (Based on Production Site)
1.3.1 World GABA Receptor Agonists Production Value by Region (2021-2032)
1.3.2 World GABA Receptor Agonists Production by Region (2021-2032)
1.3.3 World GABA Receptor Agonists Average Price by Region (2021-2032)
1.3.4 North America GABA Receptor Agonists Production (2021-2032)
1.3.5 Europe GABA Receptor Agonists Production (2021-2032)
1.3.6 China GABA Receptor Agonists Production (2021-2032)
1.3.7 Japan GABA Receptor Agonists Production (2021-2032)
1.3.8 India GABA Receptor Agonists Production (2021-2032)
1.3.9 South Korea GABA Receptor Agonists Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 GABA Receptor Agonists Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 GABA Receptor Agonists Major Market Trends
2 DEMAND SUMMARY
2.1 World GABA Receptor Agonists Demand (2021-2032)
2.2 World GABA Receptor Agonists Consumption by Region
2.2.1 World GABA Receptor Agonists Consumption by Region (2021-2026)
2.2.2 World GABA Receptor Agonists Consumption Forecast by Region (2027-2032)
2.3 United States GABA Receptor Agonists Consumption (2021-2032)
2.4 China GABA Receptor Agonists Consumption (2021-2032)
2.5 Europe GABA Receptor Agonists Consumption (2021-2032)
2.6 Japan GABA Receptor Agonists Consumption (2021-2032)
2.7 South Korea GABA Receptor Agonists Consumption (2021-2032)
2.8 ASEAN GABA Receptor Agonists Consumption (2021-2032)
2.9 India GABA Receptor Agonists Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World GABA Receptor Agonists Production Value by Manufacturer (2021-2026)
3.2 World GABA Receptor Agonists Production by Manufacturer (2021-2026)
3.3 World GABA Receptor Agonists Average Price by Manufacturer (2021-2026)
3.4 GABA Receptor Agonists Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global GABA Receptor Agonists Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for GABA Receptor Agonists in 2025
3.5.3 Global Concentration Ratios (CR8) for GABA Receptor Agonists in 2025
3.6 GABA Receptor Agonists Market: Overall Company Footprint Analysis
3.6.1 GABA Receptor Agonists Market: Region Footprint
3.6.2 GABA Receptor Agonists Market: Company Product Type Footprint
3.6.3 GABA Receptor Agonists Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: GABA Receptor Agonists Production Value Comparison
4.1.1 United States VS China: GABA Receptor Agonists Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: GABA Receptor Agonists Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: GABA Receptor Agonists Production Comparison
4.2.1 United States VS China: GABA Receptor Agonists Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: GABA Receptor Agonists Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: GABA Receptor Agonists Consumption Comparison
4.3.1 United States VS China: GABA Receptor Agonists Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: GABA Receptor Agonists Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based GABA Receptor Agonists Manufacturers and Market Share, 2021-2026
4.4.1 United States Based GABA Receptor Agonists Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers GABA Receptor Agonists Production Value (2021-2026)
4.4.3 United States Based Manufacturers GABA Receptor Agonists Production (2021-2026)
4.5 China Based GABA Receptor Agonists Manufacturers and Market Share
4.5.1 China Based GABA Receptor Agonists Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers GABA Receptor Agonists Production Value (2021-2026)
4.5.3 China Based Manufacturers GABA Receptor Agonists Production (2021-2026)
4.6 Rest of World Based GABA Receptor Agonists Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based GABA Receptor Agonists Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers GABA Receptor Agonists Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers GABA Receptor Agonists Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World GABA Receptor Agonists Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 GABA_A receptor-targeted drugs
5.2.2 GABA_B receptor-targeted drugs
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World GABA Receptor Agonists Production by Type (2021-2032)
5.3.2 World GABA Receptor Agonists Production Value by Type (2021-2032)
5.3.3 World GABA Receptor Agonists Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY PHARMACOLOGICAL ACTION MODE
6.1 World GABA Receptor Agonists Market Size Overview by Pharmacological Action Mode: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Pharmacological Action Mode
6.2.1 Direct GABA receptor agonists
6.2.2 Positive allosteric modulators
6.2.3 Others
6.3 Market Segment by Pharmacological Action Mode
6.3.1 World GABA Receptor Agonists Production by Pharmacological Action Mode (2021-2032)
6.3.2 World GABA Receptor Agonists Production Value by Pharmacological Action Mode (2021-2032)
6.3.3 World GABA Receptor Agonists Average Price by Pharmacological Action Mode (2021-2032)
7 MARKET ANALYSIS BY DOSAGE FORM
7.1 World GABA Receptor Agonists Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dosage Form
7.2.1 Oral dosage forms
7.2.2 Injectable dosage forms
7.2.3 Others
7.3 Market Segment by Dosage Form
7.3.1 World GABA Receptor Agonists Production by Dosage Form (2021-2032)
7.3.2 World GABA Receptor Agonists Production Value by Dosage Form (2021-2032)
7.3.3 World GABA Receptor Agonists Average Price by Dosage Form (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World GABA Receptor Agonists Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Attention Deficit Hyperactivity Disorder (ADHD)
8.2.2 Psychiatric Disorders and Depression
8.2.3 Alzheimer
8.2.4 Epilepsy and Seizure
8.2.5 Anxiety and Sleep Disorders
8.2.6 Obesity and Alcoholism
8.3 Market Segment by Application
8.3.1 World GABA Receptor Agonists Production by Application (2021-2032)
8.3.2 World GABA Receptor Agonists Production Value by Application (2021-2032)
8.3.3 World GABA Receptor Agonists Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Sanofi
9.1.1 Sanofi Details
9.1.2 Sanofi Major Business
9.1.3 Sanofi GABA Receptor Agonists Product and Services
9.1.4 Sanofi GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Sanofi Recent Developments/Updates
9.1.6 Sanofi Competitive Strengths & Weaknesses
9.2 Roche
9.2.1 Roche Details
9.2.2 Roche Major Business
9.2.3 Roche GABA Receptor Agonists Product and Services
9.2.4 Roche GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Roche Recent Developments/Updates
9.2.6 Roche Competitive Strengths & Weaknesses
9.3 Novartis
9.3.1 Novartis Details
9.3.2 Novartis Major Business
9.3.3 Novartis GABA Receptor Agonists Product and Services
9.3.4 Novartis GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Novartis Recent Developments/Updates
9.3.6 Novartis Competitive Strengths & Weaknesses
9.4 Viatris
9.4.1 Viatris Details
9.4.2 Viatris Major Business
9.4.3 Viatris GABA Receptor Agonists Product and Services
9.4.4 Viatris GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Viatris Recent Developments/Updates
9.4.6 Viatris Competitive Strengths & Weaknesses
9.5 Teva Pharmaceutical Industries
9.5.1 Teva Pharmaceutical Industries Details
9.5.2 Teva Pharmaceutical Industries Major Business
9.5.3 Teva Pharmaceutical Industries GABA Receptor Agonists Product and Services
9.5.4 Teva Pharmaceutical Industries GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Teva Pharmaceutical Industries Recent Developments/Updates
9.5.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
9.6 Sandoz
9.6.1 Sandoz Details
9.6.2 Sandoz Major Business
9.6.3 Sandoz GABA Receptor Agonists Product and Services
9.6.4 Sandoz GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Sandoz Recent Developments/Updates
9.6.6 Sandoz Competitive Strengths & Weaknesses
9.7 Lundbeck
9.7.1 Lundbeck Details
9.7.2 Lundbeck Major Business
9.7.3 Lundbeck GABA Receptor Agonists Product and Services
9.7.4 Lundbeck GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Lundbeck Recent Developments/Updates
9.7.6 Lundbeck Competitive Strengths & Weaknesses
9.8 Biocodex
9.8.1 Biocodex Details
9.8.2 Biocodex Major Business
9.8.3 Biocodex GABA Receptor Agonists Product and Services
9.8.4 Biocodex GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Biocodex Recent Developments/Updates
9.8.6 Biocodex Competitive Strengths & Weaknesses
9.9 Immedica Pharma
9.9.1 Immedica Pharma Details
9.9.2 Immedica Pharma Major Business
9.9.3 Immedica Pharma GABA Receptor Agonists Product and Services
9.9.4 Immedica Pharma GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Immedica Pharma Recent Developments/Updates
9.9.6 Immedica Pharma Competitive Strengths & Weaknesses
9.10 Azurity Pharmaceuticals
9.10.1 Azurity Pharmaceuticals Details
9.10.2 Azurity Pharmaceuticals Major Business
9.10.3 Azurity Pharmaceuticals GABA Receptor Agonists Product and Services
9.10.4 Azurity Pharmaceuticals GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Azurity Pharmaceuticals Recent Developments/Updates
9.10.6 Azurity Pharmaceuticals Competitive Strengths & Weaknesses
9.11 Amneal Pharmaceuticals
9.11.1 Amneal Pharmaceuticals Details
9.11.2 Amneal Pharmaceuticals Major Business
9.11.3 Amneal Pharmaceuticals GABA Receptor Agonists Product and Services
9.11.4 Amneal Pharmaceuticals GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Amneal Pharmaceuticals Recent Developments/Updates
9.11.6 Amneal Pharmaceuticals Competitive Strengths & Weaknesses
9.12 Fresenius Kabi
9.12.1 Fresenius Kabi Details
9.12.2 Fresenius Kabi Major Business
9.12.3 Fresenius Kabi GABA Receptor Agonists Product and Services
9.12.4 Fresenius Kabi GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Fresenius Kabi Recent Developments/Updates
9.12.6 Fresenius Kabi Competitive Strengths & Weaknesses
9.13 Hikma Pharmaceuticals
9.13.1 Hikma Pharmaceuticals Details
9.13.2 Hikma Pharmaceuticals Major Business
9.13.3 Hikma Pharmaceuticals GABA Receptor Agonists Product and Services
9.13.4 Hikma Pharmaceuticals GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Hikma Pharmaceuticals Recent Developments/Updates
9.13.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
9.14 Eagle Pharmaceuticals
9.14.1 Eagle Pharmaceuticals Details
9.14.2 Eagle Pharmaceuticals Major Business
9.14.3 Eagle Pharmaceuticals GABA Receptor Agonists Product and Services
9.14.4 Eagle Pharmaceuticals GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Eagle Pharmaceuticals Recent Developments/Updates
9.14.6 Eagle Pharmaceuticals Competitive Strengths & Weaknesses
9.15 PAION Pharma
9.15.1 PAION Pharma Details
9.15.2 PAION Pharma Major Business
9.15.3 PAION Pharma GABA Receptor Agonists Product and Services
9.15.4 PAION Pharma GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 PAION Pharma Recent Developments/Updates
9.15.6 PAION Pharma Competitive Strengths & Weaknesses
9.16 Mundipharma
9.16.1 Mundipharma Details
9.16.2 Mundipharma Major Business
9.16.3 Mundipharma GABA Receptor Agonists Product and Services
9.16.4 Mundipharma GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Mundipharma Recent Developments/Updates
9.16.6 Mundipharma Competitive Strengths & Weaknesses
9.17 Eisai
9.17.1 Eisai Details
9.17.2 Eisai Major Business
9.17.3 Eisai GABA Receptor Agonists Product and Services
9.17.4 Eisai GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Eisai Recent Developments/Updates
9.17.6 Eisai Competitive Strengths & Weaknesses
9.18 Sumitomo Pharma
9.18.1 Sumitomo Pharma Details
9.18.2 Sumitomo Pharma Major Business
9.18.3 Sumitomo Pharma GABA Receptor Agonists Product and Services
9.18.4 Sumitomo Pharma GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Sumitomo Pharma Recent Developments/Updates
9.18.6 Sumitomo Pharma Competitive Strengths & Weaknesses
9.19 ANI Pharmaceuticals
9.19.1 ANI Pharmaceuticals Details
9.19.2 ANI Pharmaceuticals Major Business
9.19.3 ANI Pharmaceuticals GABA Receptor Agonists Product and Services
9.19.4 ANI Pharmaceuticals GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 ANI Pharmaceuticals Recent Developments/Updates
9.19.6 ANI Pharmaceuticals Competitive Strengths & Weaknesses
9.20 Zydus Lifesciences
9.20.1 Zydus Lifesciences Details
9.20.2 Zydus Lifesciences Major Business
9.20.3 Zydus Lifesciences GABA Receptor Agonists Product and Services
9.20.4 Zydus Lifesciences GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 Zydus Lifesciences Recent Developments/Updates
9.20.6 Zydus Lifesciences Competitive Strengths & Weaknesses
9.21 Aurobindo Pharma
9.21.1 Aurobindo Pharma Details
9.21.2 Aurobindo Pharma Major Business
9.21.3 Aurobindo Pharma GABA Receptor Agonists Product and Services
9.21.4 Aurobindo Pharma GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.21.5 Aurobindo Pharma Recent Developments/Updates
9.21.6 Aurobindo Pharma Competitive Strengths & Weaknesses
9.22 Sun Pharmaceutical Industries
9.22.1 Sun Pharmaceutical Industries Details
9.22.2 Sun Pharmaceutical Industries Major Business
9.22.3 Sun Pharmaceutical Industries GABA Receptor Agonists Product and Services
9.22.4 Sun Pharmaceutical Industries GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.22.5 Sun Pharmaceutical Industries Recent Developments/Updates
9.22.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
9.23 Cipla
9.23.1 Cipla Details
9.23.2 Cipla Major Business
9.23.3 Cipla GABA Receptor Agonists Product and Services
9.23.4 Cipla GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.23.5 Cipla Recent Developments/Updates
9.23.6 Cipla Competitive Strengths & Weaknesses
9.24 Torrent Pharmaceuticals
9.24.1 Torrent Pharmaceuticals Details
9.24.2 Torrent Pharmaceuticals Major Business
9.24.3 Torrent Pharmaceuticals GABA Receptor Agonists Product and Services
9.24.4 Torrent Pharmaceuticals GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.24.5 Torrent Pharmaceuticals Recent Developments/Updates
9.24.6 Torrent Pharmaceuticals Competitive Strengths & Weaknesses
9.25 Endo
9.25.1 Endo Details
9.25.2 Endo Major Business
9.25.3 Endo GABA Receptor Agonists Product and Services
9.25.4 Endo GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.25.5 Endo Recent Developments/Updates
9.25.6 Endo Competitive Strengths & Weaknesses
9.26 Baxter
9.26.1 Baxter Details
9.26.2 Baxter Major Business
9.26.3 Baxter GABA Receptor Agonists Product and Services
9.26.4 Baxter GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.26.5 Baxter Recent Developments/Updates
9.26.6 Baxter Competitive Strengths & Weaknesses
9.27 Hameln Pharma
9.27.1 Hameln Pharma Details
9.27.2 Hameln Pharma Major Business
9.27.3 Hameln Pharma GABA Receptor Agonists Product and Services
9.27.4 Hameln Pharma GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.27.5 Hameln Pharma Recent Developments/Updates
9.27.6 Hameln Pharma Competitive Strengths & Weaknesses
9.28 Ethypharm
9.28.1 Ethypharm Details
9.28.2 Ethypharm Major Business
9.28.3 Ethypharm GABA Receptor Agonists Product and Services
9.28.4 Ethypharm GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.28.5 Ethypharm Recent Developments/Updates
9.28.6 Ethypharm Competitive Strengths & Weaknesses
9.29 Neuraxpharm
9.29.1 Neuraxpharm Details
9.29.2 Neuraxpharm Major Business
9.29.3 Neuraxpharm GABA Receptor Agonists Product and Services
9.29.4 Neuraxpharm GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.29.5 Neuraxpharm Recent Developments/Updates
9.29.6 Neuraxpharm Competitive Strengths & Weaknesses
9.30 Sawai Pharmaceutical
9.30.1 Sawai Pharmaceutical Details
9.30.2 Sawai Pharmaceutical Major Business
9.30.3 Sawai Pharmaceutical GABA Receptor Agonists Product and Services
9.30.4 Sawai Pharmaceutical GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.30.5 Sawai Pharmaceutical Recent Developments/Updates
9.30.6 Sawai Pharmaceutical Competitive Strengths & Weaknesses
9.31 Towa Pharmaceutical
9.31.1 Towa Pharmaceutical Details
9.31.2 Towa Pharmaceutical Major Business
9.31.3 Towa Pharmaceutical GABA Receptor Agonists Product and Services
9.31.4 Towa Pharmaceutical GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.31.5 Towa Pharmaceutical Recent Developments/Updates
9.31.6 Towa Pharmaceutical Competitive Strengths & Weaknesses
9.32 Nichi-Iko Pharmaceutical
9.32.1 Nichi-Iko Pharmaceutical Details
9.32.2 Nichi-Iko Pharmaceutical Major Business
9.32.3 Nichi-Iko Pharmaceutical GABA Receptor Agonists Product and Services
9.32.4 Nichi-Iko Pharmaceutical GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.32.5 Nichi-Iko Pharmaceutical Recent Developments/Updates
9.32.6 Nichi-Iko Pharmaceutical Competitive Strengths & Weaknesses
9.33 Zhejiang Jingxin Pharmaceutical
9.33.1 Zhejiang Jingxin Pharmaceutical Details
9.33.2 Zhejiang Jingxin Pharmaceutical Major Business
9.33.3 Zhejiang Jingxin Pharmaceutical GABA Receptor Agonists Product and Services
9.33.4 Zhejiang Jingxin Pharmaceutical GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.33.5 Zhejiang Jingxin Pharmaceutical Recent Developments/Updates
9.33.6 Zhejiang Jingxin Pharmaceutical Competitive Strengths & Weaknesses
9.34 Jiangsu Nhwa Pharmaceutical
9.34.1 Jiangsu Nhwa Pharmaceutical Details
9.34.2 Jiangsu Nhwa Pharmaceutical Major Business
9.34.3 Jiangsu Nhwa Pharmaceutical GABA Receptor Agonists Product and Services
9.34.4 Jiangsu Nhwa Pharmaceutical GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.34.5 Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
9.34.6 Jiangsu Nhwa Pharmaceutical Competitive Strengths & Weaknesses
9.35 Yichang Humanwell Pharmaceutical
9.35.1 Yichang Humanwell Pharmaceutical Details
9.35.2 Yichang Humanwell Pharmaceutical Major Business
9.35.3 Yichang Humanwell Pharmaceutical GABA Receptor Agonists Product and Services
9.35.4 Yichang Humanwell Pharmaceutical GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.35.5 Yichang Humanwell Pharmaceutical Recent Developments/Updates
9.35.6 Yichang Humanwell Pharmaceutical Competitive Strengths & Weaknesses
9.36 Shandong Sine Pharmaceutical
9.36.1 Shandong Sine Pharmaceutical Details
9.36.2 Shandong Sine Pharmaceutical Major Business
9.36.3 Shandong Sine Pharmaceutical GABA Receptor Agonists Product and Services
9.36.4 Shandong Sine Pharmaceutical GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.36.5 Shandong Sine Pharmaceutical Recent Developments/Updates
9.36.6 Shandong Sine Pharmaceutical Competitive Strengths & Weaknesses
9.37 Shanghai SPH Sine Pharmaceutical
9.37.1 Shanghai SPH Sine Pharmaceutical Details
9.37.2 Shanghai SPH Sine Pharmaceutical Major Business
9.37.3 Shanghai SPH Sine Pharmaceutical GABA Receptor Agonists Product and Services
9.37.4 Shanghai SPH Sine Pharmaceutical GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.37.5 Shanghai SPH Sine Pharmaceutical Recent Developments/Updates
9.37.6 Shanghai SPH Sine Pharmaceutical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 GABA Receptor Agonists Industry Chain
10.2 GABA Receptor Agonists Upstream Analysis
10.2.1 GABA Receptor Agonists Core Raw Materials
10.2.2 Main Manufacturers of GABA Receptor Agonists Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 GABA Receptor Agonists Production Mode
10.6 GABA Receptor Agonists Procurement Model
10.7 GABA Receptor Agonists Industry Sales Model and Sales Channels
10.7.1 GABA Receptor Agonists Sales Model
10.7.2 GABA Receptor Agonists Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 GABA Receptor Agonists Introduction
1.2 World GABA Receptor Agonists Supply & Forecast
1.2.1 World GABA Receptor Agonists Production Value (2021 & 2025 & 2032)
1.2.2 World GABA Receptor Agonists Production (2021-2032)
1.2.3 World GABA Receptor Agonists Pricing Trends (2021-2032)
1.3 World GABA Receptor Agonists Production by Region (Based on Production Site)
1.3.1 World GABA Receptor Agonists Production Value by Region (2021-2032)
1.3.2 World GABA Receptor Agonists Production by Region (2021-2032)
1.3.3 World GABA Receptor Agonists Average Price by Region (2021-2032)
1.3.4 North America GABA Receptor Agonists Production (2021-2032)
1.3.5 Europe GABA Receptor Agonists Production (2021-2032)
1.3.6 China GABA Receptor Agonists Production (2021-2032)
1.3.7 Japan GABA Receptor Agonists Production (2021-2032)
1.3.8 India GABA Receptor Agonists Production (2021-2032)
1.3.9 South Korea GABA Receptor Agonists Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 GABA Receptor Agonists Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 GABA Receptor Agonists Major Market Trends
2 DEMAND SUMMARY
2.1 World GABA Receptor Agonists Demand (2021-2032)
2.2 World GABA Receptor Agonists Consumption by Region
2.2.1 World GABA Receptor Agonists Consumption by Region (2021-2026)
2.2.2 World GABA Receptor Agonists Consumption Forecast by Region (2027-2032)
2.3 United States GABA Receptor Agonists Consumption (2021-2032)
2.4 China GABA Receptor Agonists Consumption (2021-2032)
2.5 Europe GABA Receptor Agonists Consumption (2021-2032)
2.6 Japan GABA Receptor Agonists Consumption (2021-2032)
2.7 South Korea GABA Receptor Agonists Consumption (2021-2032)
2.8 ASEAN GABA Receptor Agonists Consumption (2021-2032)
2.9 India GABA Receptor Agonists Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World GABA Receptor Agonists Production Value by Manufacturer (2021-2026)
3.2 World GABA Receptor Agonists Production by Manufacturer (2021-2026)
3.3 World GABA Receptor Agonists Average Price by Manufacturer (2021-2026)
3.4 GABA Receptor Agonists Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global GABA Receptor Agonists Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for GABA Receptor Agonists in 2025
3.5.3 Global Concentration Ratios (CR8) for GABA Receptor Agonists in 2025
3.6 GABA Receptor Agonists Market: Overall Company Footprint Analysis
3.6.1 GABA Receptor Agonists Market: Region Footprint
3.6.2 GABA Receptor Agonists Market: Company Product Type Footprint
3.6.3 GABA Receptor Agonists Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: GABA Receptor Agonists Production Value Comparison
4.1.1 United States VS China: GABA Receptor Agonists Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: GABA Receptor Agonists Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: GABA Receptor Agonists Production Comparison
4.2.1 United States VS China: GABA Receptor Agonists Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: GABA Receptor Agonists Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: GABA Receptor Agonists Consumption Comparison
4.3.1 United States VS China: GABA Receptor Agonists Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: GABA Receptor Agonists Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based GABA Receptor Agonists Manufacturers and Market Share, 2021-2026
4.4.1 United States Based GABA Receptor Agonists Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers GABA Receptor Agonists Production Value (2021-2026)
4.4.3 United States Based Manufacturers GABA Receptor Agonists Production (2021-2026)
4.5 China Based GABA Receptor Agonists Manufacturers and Market Share
4.5.1 China Based GABA Receptor Agonists Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers GABA Receptor Agonists Production Value (2021-2026)
4.5.3 China Based Manufacturers GABA Receptor Agonists Production (2021-2026)
4.6 Rest of World Based GABA Receptor Agonists Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based GABA Receptor Agonists Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers GABA Receptor Agonists Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers GABA Receptor Agonists Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World GABA Receptor Agonists Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 GABA_A receptor-targeted drugs
5.2.2 GABA_B receptor-targeted drugs
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World GABA Receptor Agonists Production by Type (2021-2032)
5.3.2 World GABA Receptor Agonists Production Value by Type (2021-2032)
5.3.3 World GABA Receptor Agonists Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY PHARMACOLOGICAL ACTION MODE
6.1 World GABA Receptor Agonists Market Size Overview by Pharmacological Action Mode: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Pharmacological Action Mode
6.2.1 Direct GABA receptor agonists
6.2.2 Positive allosteric modulators
6.2.3 Others
6.3 Market Segment by Pharmacological Action Mode
6.3.1 World GABA Receptor Agonists Production by Pharmacological Action Mode (2021-2032)
6.3.2 World GABA Receptor Agonists Production Value by Pharmacological Action Mode (2021-2032)
6.3.3 World GABA Receptor Agonists Average Price by Pharmacological Action Mode (2021-2032)
7 MARKET ANALYSIS BY DOSAGE FORM
7.1 World GABA Receptor Agonists Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dosage Form
7.2.1 Oral dosage forms
7.2.2 Injectable dosage forms
7.2.3 Others
7.3 Market Segment by Dosage Form
7.3.1 World GABA Receptor Agonists Production by Dosage Form (2021-2032)
7.3.2 World GABA Receptor Agonists Production Value by Dosage Form (2021-2032)
7.3.3 World GABA Receptor Agonists Average Price by Dosage Form (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World GABA Receptor Agonists Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Attention Deficit Hyperactivity Disorder (ADHD)
8.2.2 Psychiatric Disorders and Depression
8.2.3 Alzheimer
8.2.4 Epilepsy and Seizure
8.2.5 Anxiety and Sleep Disorders
8.2.6 Obesity and Alcoholism
8.3 Market Segment by Application
8.3.1 World GABA Receptor Agonists Production by Application (2021-2032)
8.3.2 World GABA Receptor Agonists Production Value by Application (2021-2032)
8.3.3 World GABA Receptor Agonists Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Sanofi
9.1.1 Sanofi Details
9.1.2 Sanofi Major Business
9.1.3 Sanofi GABA Receptor Agonists Product and Services
9.1.4 Sanofi GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Sanofi Recent Developments/Updates
9.1.6 Sanofi Competitive Strengths & Weaknesses
9.2 Roche
9.2.1 Roche Details
9.2.2 Roche Major Business
9.2.3 Roche GABA Receptor Agonists Product and Services
9.2.4 Roche GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Roche Recent Developments/Updates
9.2.6 Roche Competitive Strengths & Weaknesses
9.3 Novartis
9.3.1 Novartis Details
9.3.2 Novartis Major Business
9.3.3 Novartis GABA Receptor Agonists Product and Services
9.3.4 Novartis GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Novartis Recent Developments/Updates
9.3.6 Novartis Competitive Strengths & Weaknesses
9.4 Viatris
9.4.1 Viatris Details
9.4.2 Viatris Major Business
9.4.3 Viatris GABA Receptor Agonists Product and Services
9.4.4 Viatris GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Viatris Recent Developments/Updates
9.4.6 Viatris Competitive Strengths & Weaknesses
9.5 Teva Pharmaceutical Industries
9.5.1 Teva Pharmaceutical Industries Details
9.5.2 Teva Pharmaceutical Industries Major Business
9.5.3 Teva Pharmaceutical Industries GABA Receptor Agonists Product and Services
9.5.4 Teva Pharmaceutical Industries GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Teva Pharmaceutical Industries Recent Developments/Updates
9.5.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
9.6 Sandoz
9.6.1 Sandoz Details
9.6.2 Sandoz Major Business
9.6.3 Sandoz GABA Receptor Agonists Product and Services
9.6.4 Sandoz GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Sandoz Recent Developments/Updates
9.6.6 Sandoz Competitive Strengths & Weaknesses
9.7 Lundbeck
9.7.1 Lundbeck Details
9.7.2 Lundbeck Major Business
9.7.3 Lundbeck GABA Receptor Agonists Product and Services
9.7.4 Lundbeck GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Lundbeck Recent Developments/Updates
9.7.6 Lundbeck Competitive Strengths & Weaknesses
9.8 Biocodex
9.8.1 Biocodex Details
9.8.2 Biocodex Major Business
9.8.3 Biocodex GABA Receptor Agonists Product and Services
9.8.4 Biocodex GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Biocodex Recent Developments/Updates
9.8.6 Biocodex Competitive Strengths & Weaknesses
9.9 Immedica Pharma
9.9.1 Immedica Pharma Details
9.9.2 Immedica Pharma Major Business
9.9.3 Immedica Pharma GABA Receptor Agonists Product and Services
9.9.4 Immedica Pharma GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Immedica Pharma Recent Developments/Updates
9.9.6 Immedica Pharma Competitive Strengths & Weaknesses
9.10 Azurity Pharmaceuticals
9.10.1 Azurity Pharmaceuticals Details
9.10.2 Azurity Pharmaceuticals Major Business
9.10.3 Azurity Pharmaceuticals GABA Receptor Agonists Product and Services
9.10.4 Azurity Pharmaceuticals GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Azurity Pharmaceuticals Recent Developments/Updates
9.10.6 Azurity Pharmaceuticals Competitive Strengths & Weaknesses
9.11 Amneal Pharmaceuticals
9.11.1 Amneal Pharmaceuticals Details
9.11.2 Amneal Pharmaceuticals Major Business
9.11.3 Amneal Pharmaceuticals GABA Receptor Agonists Product and Services
9.11.4 Amneal Pharmaceuticals GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Amneal Pharmaceuticals Recent Developments/Updates
9.11.6 Amneal Pharmaceuticals Competitive Strengths & Weaknesses
9.12 Fresenius Kabi
9.12.1 Fresenius Kabi Details
9.12.2 Fresenius Kabi Major Business
9.12.3 Fresenius Kabi GABA Receptor Agonists Product and Services
9.12.4 Fresenius Kabi GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Fresenius Kabi Recent Developments/Updates
9.12.6 Fresenius Kabi Competitive Strengths & Weaknesses
9.13 Hikma Pharmaceuticals
9.13.1 Hikma Pharmaceuticals Details
9.13.2 Hikma Pharmaceuticals Major Business
9.13.3 Hikma Pharmaceuticals GABA Receptor Agonists Product and Services
9.13.4 Hikma Pharmaceuticals GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Hikma Pharmaceuticals Recent Developments/Updates
9.13.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
9.14 Eagle Pharmaceuticals
9.14.1 Eagle Pharmaceuticals Details
9.14.2 Eagle Pharmaceuticals Major Business
9.14.3 Eagle Pharmaceuticals GABA Receptor Agonists Product and Services
9.14.4 Eagle Pharmaceuticals GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Eagle Pharmaceuticals Recent Developments/Updates
9.14.6 Eagle Pharmaceuticals Competitive Strengths & Weaknesses
9.15 PAION Pharma
9.15.1 PAION Pharma Details
9.15.2 PAION Pharma Major Business
9.15.3 PAION Pharma GABA Receptor Agonists Product and Services
9.15.4 PAION Pharma GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 PAION Pharma Recent Developments/Updates
9.15.6 PAION Pharma Competitive Strengths & Weaknesses
9.16 Mundipharma
9.16.1 Mundipharma Details
9.16.2 Mundipharma Major Business
9.16.3 Mundipharma GABA Receptor Agonists Product and Services
9.16.4 Mundipharma GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Mundipharma Recent Developments/Updates
9.16.6 Mundipharma Competitive Strengths & Weaknesses
9.17 Eisai
9.17.1 Eisai Details
9.17.2 Eisai Major Business
9.17.3 Eisai GABA Receptor Agonists Product and Services
9.17.4 Eisai GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Eisai Recent Developments/Updates
9.17.6 Eisai Competitive Strengths & Weaknesses
9.18 Sumitomo Pharma
9.18.1 Sumitomo Pharma Details
9.18.2 Sumitomo Pharma Major Business
9.18.3 Sumitomo Pharma GABA Receptor Agonists Product and Services
9.18.4 Sumitomo Pharma GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Sumitomo Pharma Recent Developments/Updates
9.18.6 Sumitomo Pharma Competitive Strengths & Weaknesses
9.19 ANI Pharmaceuticals
9.19.1 ANI Pharmaceuticals Details
9.19.2 ANI Pharmaceuticals Major Business
9.19.3 ANI Pharmaceuticals GABA Receptor Agonists Product and Services
9.19.4 ANI Pharmaceuticals GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 ANI Pharmaceuticals Recent Developments/Updates
9.19.6 ANI Pharmaceuticals Competitive Strengths & Weaknesses
9.20 Zydus Lifesciences
9.20.1 Zydus Lifesciences Details
9.20.2 Zydus Lifesciences Major Business
9.20.3 Zydus Lifesciences GABA Receptor Agonists Product and Services
9.20.4 Zydus Lifesciences GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 Zydus Lifesciences Recent Developments/Updates
9.20.6 Zydus Lifesciences Competitive Strengths & Weaknesses
9.21 Aurobindo Pharma
9.21.1 Aurobindo Pharma Details
9.21.2 Aurobindo Pharma Major Business
9.21.3 Aurobindo Pharma GABA Receptor Agonists Product and Services
9.21.4 Aurobindo Pharma GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.21.5 Aurobindo Pharma Recent Developments/Updates
9.21.6 Aurobindo Pharma Competitive Strengths & Weaknesses
9.22 Sun Pharmaceutical Industries
9.22.1 Sun Pharmaceutical Industries Details
9.22.2 Sun Pharmaceutical Industries Major Business
9.22.3 Sun Pharmaceutical Industries GABA Receptor Agonists Product and Services
9.22.4 Sun Pharmaceutical Industries GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.22.5 Sun Pharmaceutical Industries Recent Developments/Updates
9.22.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
9.23 Cipla
9.23.1 Cipla Details
9.23.2 Cipla Major Business
9.23.3 Cipla GABA Receptor Agonists Product and Services
9.23.4 Cipla GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.23.5 Cipla Recent Developments/Updates
9.23.6 Cipla Competitive Strengths & Weaknesses
9.24 Torrent Pharmaceuticals
9.24.1 Torrent Pharmaceuticals Details
9.24.2 Torrent Pharmaceuticals Major Business
9.24.3 Torrent Pharmaceuticals GABA Receptor Agonists Product and Services
9.24.4 Torrent Pharmaceuticals GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.24.5 Torrent Pharmaceuticals Recent Developments/Updates
9.24.6 Torrent Pharmaceuticals Competitive Strengths & Weaknesses
9.25 Endo
9.25.1 Endo Details
9.25.2 Endo Major Business
9.25.3 Endo GABA Receptor Agonists Product and Services
9.25.4 Endo GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.25.5 Endo Recent Developments/Updates
9.25.6 Endo Competitive Strengths & Weaknesses
9.26 Baxter
9.26.1 Baxter Details
9.26.2 Baxter Major Business
9.26.3 Baxter GABA Receptor Agonists Product and Services
9.26.4 Baxter GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.26.5 Baxter Recent Developments/Updates
9.26.6 Baxter Competitive Strengths & Weaknesses
9.27 Hameln Pharma
9.27.1 Hameln Pharma Details
9.27.2 Hameln Pharma Major Business
9.27.3 Hameln Pharma GABA Receptor Agonists Product and Services
9.27.4 Hameln Pharma GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.27.5 Hameln Pharma Recent Developments/Updates
9.27.6 Hameln Pharma Competitive Strengths & Weaknesses
9.28 Ethypharm
9.28.1 Ethypharm Details
9.28.2 Ethypharm Major Business
9.28.3 Ethypharm GABA Receptor Agonists Product and Services
9.28.4 Ethypharm GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.28.5 Ethypharm Recent Developments/Updates
9.28.6 Ethypharm Competitive Strengths & Weaknesses
9.29 Neuraxpharm
9.29.1 Neuraxpharm Details
9.29.2 Neuraxpharm Major Business
9.29.3 Neuraxpharm GABA Receptor Agonists Product and Services
9.29.4 Neuraxpharm GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.29.5 Neuraxpharm Recent Developments/Updates
9.29.6 Neuraxpharm Competitive Strengths & Weaknesses
9.30 Sawai Pharmaceutical
9.30.1 Sawai Pharmaceutical Details
9.30.2 Sawai Pharmaceutical Major Business
9.30.3 Sawai Pharmaceutical GABA Receptor Agonists Product and Services
9.30.4 Sawai Pharmaceutical GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.30.5 Sawai Pharmaceutical Recent Developments/Updates
9.30.6 Sawai Pharmaceutical Competitive Strengths & Weaknesses
9.31 Towa Pharmaceutical
9.31.1 Towa Pharmaceutical Details
9.31.2 Towa Pharmaceutical Major Business
9.31.3 Towa Pharmaceutical GABA Receptor Agonists Product and Services
9.31.4 Towa Pharmaceutical GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.31.5 Towa Pharmaceutical Recent Developments/Updates
9.31.6 Towa Pharmaceutical Competitive Strengths & Weaknesses
9.32 Nichi-Iko Pharmaceutical
9.32.1 Nichi-Iko Pharmaceutical Details
9.32.2 Nichi-Iko Pharmaceutical Major Business
9.32.3 Nichi-Iko Pharmaceutical GABA Receptor Agonists Product and Services
9.32.4 Nichi-Iko Pharmaceutical GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.32.5 Nichi-Iko Pharmaceutical Recent Developments/Updates
9.32.6 Nichi-Iko Pharmaceutical Competitive Strengths & Weaknesses
9.33 Zhejiang Jingxin Pharmaceutical
9.33.1 Zhejiang Jingxin Pharmaceutical Details
9.33.2 Zhejiang Jingxin Pharmaceutical Major Business
9.33.3 Zhejiang Jingxin Pharmaceutical GABA Receptor Agonists Product and Services
9.33.4 Zhejiang Jingxin Pharmaceutical GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.33.5 Zhejiang Jingxin Pharmaceutical Recent Developments/Updates
9.33.6 Zhejiang Jingxin Pharmaceutical Competitive Strengths & Weaknesses
9.34 Jiangsu Nhwa Pharmaceutical
9.34.1 Jiangsu Nhwa Pharmaceutical Details
9.34.2 Jiangsu Nhwa Pharmaceutical Major Business
9.34.3 Jiangsu Nhwa Pharmaceutical GABA Receptor Agonists Product and Services
9.34.4 Jiangsu Nhwa Pharmaceutical GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.34.5 Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
9.34.6 Jiangsu Nhwa Pharmaceutical Competitive Strengths & Weaknesses
9.35 Yichang Humanwell Pharmaceutical
9.35.1 Yichang Humanwell Pharmaceutical Details
9.35.2 Yichang Humanwell Pharmaceutical Major Business
9.35.3 Yichang Humanwell Pharmaceutical GABA Receptor Agonists Product and Services
9.35.4 Yichang Humanwell Pharmaceutical GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.35.5 Yichang Humanwell Pharmaceutical Recent Developments/Updates
9.35.6 Yichang Humanwell Pharmaceutical Competitive Strengths & Weaknesses
9.36 Shandong Sine Pharmaceutical
9.36.1 Shandong Sine Pharmaceutical Details
9.36.2 Shandong Sine Pharmaceutical Major Business
9.36.3 Shandong Sine Pharmaceutical GABA Receptor Agonists Product and Services
9.36.4 Shandong Sine Pharmaceutical GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.36.5 Shandong Sine Pharmaceutical Recent Developments/Updates
9.36.6 Shandong Sine Pharmaceutical Competitive Strengths & Weaknesses
9.37 Shanghai SPH Sine Pharmaceutical
9.37.1 Shanghai SPH Sine Pharmaceutical Details
9.37.2 Shanghai SPH Sine Pharmaceutical Major Business
9.37.3 Shanghai SPH Sine Pharmaceutical GABA Receptor Agonists Product and Services
9.37.4 Shanghai SPH Sine Pharmaceutical GABA Receptor Agonists Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.37.5 Shanghai SPH Sine Pharmaceutical Recent Developments/Updates
9.37.6 Shanghai SPH Sine Pharmaceutical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 GABA Receptor Agonists Industry Chain
10.2 GABA Receptor Agonists Upstream Analysis
10.2.1 GABA Receptor Agonists Core Raw Materials
10.2.2 Main Manufacturers of GABA Receptor Agonists Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 GABA Receptor Agonists Production Mode
10.6 GABA Receptor Agonists Procurement Model
10.7 GABA Receptor Agonists Industry Sales Model and Sales Channels
10.7.1 GABA Receptor Agonists Sales Model
10.7.2 GABA Receptor Agonists Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World GABA Receptor Agonists Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World GABA Receptor Agonists Production Value by Region (2021-2026) & (USD Million)
Table 3. World GABA Receptor Agonists Production Value by Region (2027-2032) & (USD Million)
Table 4. World GABA Receptor Agonists Production Value Market Share by Region (2021-2026)
Table 5. World GABA Receptor Agonists Production Value Market Share by Region (2027-2032)
Table 6. World GABA Receptor Agonists Production by Region (2021-2026) & (K Dose)
Table 7. World GABA Receptor Agonists Production by Region (2027-2032) & (K Dose)
Table 8. World GABA Receptor Agonists Production Market Share by Region (2021-2026)
Table 9. World GABA Receptor Agonists Production Market Share by Region (2027-2032)
Table 10. World GABA Receptor Agonists Average Price by Region (2021-2026) & (USD/Pcs)
Table 11. World GABA Receptor Agonists Average Price by Region (2027-2032) & (USD/Pcs)
Table 12. GABA Receptor Agonists Major Market Trends
Table 13. World GABA Receptor Agonists Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World GABA Receptor Agonists Consumption by Region (2021-2026) & (K Dose)
Table 15. World GABA Receptor Agonists Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World GABA Receptor Agonists Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key GABA Receptor Agonists Producers in 2025
Table 18. World GABA Receptor Agonists Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key GABA Receptor Agonists Producers in 2025
Table 20. World GABA Receptor Agonists Average Price by Manufacturer (2021-2026) & (USD/Pcs)
Table 21. Global GABA Receptor Agonists Company Evaluation Quadrant
Table 22. World GABA Receptor Agonists Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and GABA Receptor Agonists Production Site of Key Manufacturer
Table 24. GABA Receptor Agonists Market: Company Product Type Footprint
Table 25. GABA Receptor Agonists Market: Company Product Application Footprint
Table 26. GABA Receptor Agonists Competitive Factors
Table 27. GABA Receptor Agonists New Entrant and Capacity Expansion Plans
Table 28. GABA Receptor Agonists Mergers & Acquisitions Activity
Table 29. United States VS China GABA Receptor Agonists Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China GABA Receptor Agonists Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China GABA Receptor Agonists Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based GABA Receptor Agonists Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers GABA Receptor Agonists Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers GABA Receptor Agonists Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers GABA Receptor Agonists Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers GABA Receptor Agonists Production Market Share (2021-2026)
Table 37. China Based GABA Receptor Agonists Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers GABA Receptor Agonists Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers GABA Receptor Agonists Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers GABA Receptor Agonists Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers GABA Receptor Agonists Production Market Share (2021-2026)
Table 42. Rest of World Based GABA Receptor Agonists Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers GABA Receptor Agonists Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers GABA Receptor Agonists Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers GABA Receptor Agonists Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers GABA Receptor Agonists Production Market Share (2021-2026)
Table 47. World GABA Receptor Agonists Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World GABA Receptor Agonists Production by Type (2021-2026) & (K Dose)
Table 49. World GABA Receptor Agonists Production by Type (2027-2032) & (K Dose)
Table 50. World GABA Receptor Agonists Production Value by Type (2021-2026) & (USD Million)
Table 51. World GABA Receptor Agonists Production Value by Type (2027-2032) & (USD Million)
Table 52. World GABA Receptor Agonists Average Price by Type (2021-2026) & (USD/Pcs)
Table 53. World GABA Receptor Agonists Average Price by Type (2027-2032) & (USD/Pcs)
Table 54. World GABA Receptor Agonists Production Value by Pharmacological Action Mode, (USD Million), 2021 & 2025 & 2032
Table 55. World GABA Receptor Agonists Production by Pharmacological Action Mode (2021-2026) & (K Dose)
Table 56. World GABA Receptor Agonists Production by Pharmacological Action Mode (2027-2032) & (K Dose)
Table 57. World GABA Receptor Agonists Production Value by Pharmacological Action Mode (2021-2026) & (USD Million)
Table 58. World GABA Receptor Agonists Production Value by Pharmacological Action Mode (2027-2032) & (USD Million)
Table 59. World GABA Receptor Agonists Average Price by Pharmacological Action Mode (2021-2026) & (USD/Pcs)
Table 60. World GABA Receptor Agonists Average Price by Pharmacological Action Mode (2027-2032) & (USD/Pcs)
Table 61. World GABA Receptor Agonists Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 62. World GABA Receptor Agonists Production by Dosage Form (2021-2026) & (K Dose)
Table 63. World GABA Receptor Agonists Production by Dosage Form (2027-2032) & (K Dose)
Table 64. World GABA Receptor Agonists Production Value by Dosage Form (2021-2026) & (USD Million)
Table 65. World GABA Receptor Agonists Production Value by Dosage Form (2027-2032) & (USD Million)
Table 66. World GABA Receptor Agonists Average Price by Dosage Form (2021-2026) & (USD/Pcs)
Table 67. World GABA Receptor Agonists Average Price by Dosage Form (2027-2032) & (USD/Pcs)
Table 68. World GABA Receptor Agonists Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World GABA Receptor Agonists Production by Application (2021-2026) & (K Dose)
Table 70. World GABA Receptor Agonists Production by Application (2027-2032) & (K Dose)
Table 71. World GABA Receptor Agonists Production Value by Application (2021-2026) & (USD Million)
Table 72. World GABA Receptor Agonists Production Value by Application (2027-2032) & (USD Million)
Table 73. World GABA Receptor Agonists Average Price by Application (2021-2026) & (USD/Pcs)
Table 74. World GABA Receptor Agonists Average Price by Application (2027-2032) & (USD/Pcs)
Table 75. Sanofi Basic Information, Manufacturing Base and Competitors
Table 76. Sanofi Major Business
Table 77. Sanofi GABA Receptor Agonists Product and Services
Table 78. Sanofi GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Sanofi Recent Developments/Updates
Table 80. Sanofi Competitive Strengths & Weaknesses
Table 81. Roche Basic Information, Manufacturing Base and Competitors
Table 82. Roche Major Business
Table 83. Roche GABA Receptor Agonists Product and Services
Table 84. Roche GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Roche Recent Developments/Updates
Table 86. Roche Competitive Strengths & Weaknesses
Table 87. Novartis Basic Information, Manufacturing Base and Competitors
Table 88. Novartis Major Business
Table 89. Novartis GABA Receptor Agonists Product and Services
Table 90. Novartis GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Novartis Recent Developments/Updates
Table 92. Novartis Competitive Strengths & Weaknesses
Table 93. Viatris Basic Information, Manufacturing Base and Competitors
Table 94. Viatris Major Business
Table 95. Viatris GABA Receptor Agonists Product and Services
Table 96. Viatris GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Viatris Recent Developments/Updates
Table 98. Viatris Competitive Strengths & Weaknesses
Table 99. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 100. Teva Pharmaceutical Industries Major Business
Table 101. Teva Pharmaceutical Industries GABA Receptor Agonists Product and Services
Table 102. Teva Pharmaceutical Industries GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Teva Pharmaceutical Industries Recent Developments/Updates
Table 104. Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 105. Sandoz Basic Information, Manufacturing Base and Competitors
Table 106. Sandoz Major Business
Table 107. Sandoz GABA Receptor Agonists Product and Services
Table 108. Sandoz GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Sandoz Recent Developments/Updates
Table 110. Sandoz Competitive Strengths & Weaknesses
Table 111. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 112. Lundbeck Major Business
Table 113. Lundbeck GABA Receptor Agonists Product and Services
Table 114. Lundbeck GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Lundbeck Recent Developments/Updates
Table 116. Lundbeck Competitive Strengths & Weaknesses
Table 117. Biocodex Basic Information, Manufacturing Base and Competitors
Table 118. Biocodex Major Business
Table 119. Biocodex GABA Receptor Agonists Product and Services
Table 120. Biocodex GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Biocodex Recent Developments/Updates
Table 122. Biocodex Competitive Strengths & Weaknesses
Table 123. Immedica Pharma Basic Information, Manufacturing Base and Competitors
Table 124. Immedica Pharma Major Business
Table 125. Immedica Pharma GABA Receptor Agonists Product and Services
Table 126. Immedica Pharma GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Immedica Pharma Recent Developments/Updates
Table 128. Immedica Pharma Competitive Strengths & Weaknesses
Table 129. Azurity Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 130. Azurity Pharmaceuticals Major Business
Table 131. Azurity Pharmaceuticals GABA Receptor Agonists Product and Services
Table 132. Azurity Pharmaceuticals GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Azurity Pharmaceuticals Recent Developments/Updates
Table 134. Azurity Pharmaceuticals Competitive Strengths & Weaknesses
Table 135. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 136. Amneal Pharmaceuticals Major Business
Table 137. Amneal Pharmaceuticals GABA Receptor Agonists Product and Services
Table 138. Amneal Pharmaceuticals GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Amneal Pharmaceuticals Recent Developments/Updates
Table 140. Amneal Pharmaceuticals Competitive Strengths & Weaknesses
Table 141. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 142. Fresenius Kabi Major Business
Table 143. Fresenius Kabi GABA Receptor Agonists Product and Services
Table 144. Fresenius Kabi GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Fresenius Kabi Recent Developments/Updates
Table 146. Fresenius Kabi Competitive Strengths & Weaknesses
Table 147. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 148. Hikma Pharmaceuticals Major Business
Table 149. Hikma Pharmaceuticals GABA Receptor Agonists Product and Services
Table 150. Hikma Pharmaceuticals GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Hikma Pharmaceuticals Recent Developments/Updates
Table 152. Hikma Pharmaceuticals Competitive Strengths & Weaknesses
Table 153. Eagle Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 154. Eagle Pharmaceuticals Major Business
Table 155. Eagle Pharmaceuticals GABA Receptor Agonists Product and Services
Table 156. Eagle Pharmaceuticals GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Eagle Pharmaceuticals Recent Developments/Updates
Table 158. Eagle Pharmaceuticals Competitive Strengths & Weaknesses
Table 159. PAION Pharma Basic Information, Manufacturing Base and Competitors
Table 160. PAION Pharma Major Business
Table 161. PAION Pharma GABA Receptor Agonists Product and Services
Table 162. PAION Pharma GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. PAION Pharma Recent Developments/Updates
Table 164. PAION Pharma Competitive Strengths & Weaknesses
Table 165. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 166. Mundipharma Major Business
Table 167. Mundipharma GABA Receptor Agonists Product and Services
Table 168. Mundipharma GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Mundipharma Recent Developments/Updates
Table 170. Mundipharma Competitive Strengths & Weaknesses
Table 171. Eisai Basic Information, Manufacturing Base and Competitors
Table 172. Eisai Major Business
Table 173. Eisai GABA Receptor Agonists Product and Services
Table 174. Eisai GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Eisai Recent Developments/Updates
Table 176. Eisai Competitive Strengths & Weaknesses
Table 177. Sumitomo Pharma Basic Information, Manufacturing Base and Competitors
Table 178. Sumitomo Pharma Major Business
Table 179. Sumitomo Pharma GABA Receptor Agonists Product and Services
Table 180. Sumitomo Pharma GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Sumitomo Pharma Recent Developments/Updates
Table 182. Sumitomo Pharma Competitive Strengths & Weaknesses
Table 183. ANI Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 184. ANI Pharmaceuticals Major Business
Table 185. ANI Pharmaceuticals GABA Receptor Agonists Product and Services
Table 186. ANI Pharmaceuticals GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. ANI Pharmaceuticals Recent Developments/Updates
Table 188. ANI Pharmaceuticals Competitive Strengths & Weaknesses
Table 189. Zydus Lifesciences Basic Information, Manufacturing Base and Competitors
Table 190. Zydus Lifesciences Major Business
Table 191. Zydus Lifesciences GABA Receptor Agonists Product and Services
Table 192. Zydus Lifesciences GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. Zydus Lifesciences Recent Developments/Updates
Table 194. Zydus Lifesciences Competitive Strengths & Weaknesses
Table 195. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 196. Aurobindo Pharma Major Business
Table 197. Aurobindo Pharma GABA Receptor Agonists Product and Services
Table 198. Aurobindo Pharma GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 199. Aurobindo Pharma Recent Developments/Updates
Table 200. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 201. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 202. Sun Pharmaceutical Industries Major Business
Table 203. Sun Pharmaceutical Industries GABA Receptor Agonists Product and Services
Table 204. Sun Pharmaceutical Industries GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. Sun Pharmaceutical Industries Recent Developments/Updates
Table 206. Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 207. Cipla Basic Information, Manufacturing Base and Competitors
Table 208. Cipla Major Business
Table 209. Cipla GABA Receptor Agonists Product and Services
Table 210. Cipla GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 211. Cipla Recent Developments/Updates
Table 212. Cipla Competitive Strengths & Weaknesses
Table 213. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 214. Torrent Pharmaceuticals Major Business
Table 215. Torrent Pharmaceuticals GABA Receptor Agonists Product and Services
Table 216. Torrent Pharmaceuticals GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 217. Torrent Pharmaceuticals Recent Developments/Updates
Table 218. Torrent Pharmaceuticals Competitive Strengths & Weaknesses
Table 219. Endo Basic Information, Manufacturing Base and Competitors
Table 220. Endo Major Business
Table 221. Endo GABA Receptor Agonists Product and Services
Table 222. Endo GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 223. Endo Recent Developments/Updates
Table 224. Endo Competitive Strengths & Weaknesses
Table 225. Baxter Basic Information, Manufacturing Base and Competitors
Table 226. Baxter Major Business
Table 227. Baxter GABA Receptor Agonists Product and Services
Table 228. Baxter GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 229. Baxter Recent Developments/Updates
Table 230. Baxter Competitive Strengths & Weaknesses
Table 231. Hameln Pharma Basic Information, Manufacturing Base and Competitors
Table 232. Hameln Pharma Major Business
Table 233. Hameln Pharma GABA Receptor Agonists Product and Services
Table 234. Hameln Pharma GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 235. Hameln Pharma Recent Developments/Updates
Table 236. Hameln Pharma Competitive Strengths & Weaknesses
Table 237. Ethypharm Basic Information, Manufacturing Base and Competitors
Table 238. Ethypharm Major Business
Table 239. Ethypharm GABA Receptor Agonists Product and Services
Table 240. Ethypharm GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 241. Ethypharm Recent Developments/Updates
Table 242. Ethypharm Competitive Strengths & Weaknesses
Table 243. Neuraxpharm Basic Information, Manufacturing Base and Competitors
Table 244. Neuraxpharm Major Business
Table 245. Neuraxpharm GABA Receptor Agonists Product and Services
Table 246. Neuraxpharm GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 247. Neuraxpharm Recent Developments/Updates
Table 248. Neuraxpharm Competitive Strengths & Weaknesses
Table 249. Sawai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 250. Sawai Pharmaceutical Major Business
Table 251. Sawai Pharmaceutical GABA Receptor Agonists Product and Services
Table 252. Sawai Pharmaceutical GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 253. Sawai Pharmaceutical Recent Developments/Updates
Table 254. Sawai Pharmaceutical Competitive Strengths & Weaknesses
Table 255. Towa Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 256. Towa Pharmaceutical Major Business
Table 257. Towa Pharmaceutical GABA Receptor Agonists Product and Services
Table 258. Towa Pharmaceutical GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 259. Towa Pharmaceutical Recent Developments/Updates
Table 260. Towa Pharmaceutical Competitive Strengths & Weaknesses
Table 261. Nichi-Iko Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 262. Nichi-Iko Pharmaceutical Major Business
Table 263. Nichi-Iko Pharmaceutical GABA Receptor Agonists Product and Services
Table 264. Nichi-Iko Pharmaceutical GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 265. Nichi-Iko Pharmaceutical Recent Developments/Updates
Table 266. Nichi-Iko Pharmaceutical Competitive Strengths & Weaknesses
Table 267. Zhejiang Jingxin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 268. Zhejiang Jingxin Pharmaceutical Major Business
Table 269. Zhejiang Jingxin Pharmaceutical GABA Receptor Agonists Product and Services
Table 270. Zhejiang Jingxin Pharmaceutical GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 271. Zhejiang Jingxin Pharmaceutical Recent Developments/Updates
Table 272. Zhejiang Jingxin Pharmaceutical Competitive Strengths & Weaknesses
Table 273. Jiangsu Nhwa Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 274. Jiangsu Nhwa Pharmaceutical Major Business
Table 275. Jiangsu Nhwa Pharmaceutical GABA Receptor Agonists Product and Services
Table 276. Jiangsu Nhwa Pharmaceutical GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 277. Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
Table 278. Jiangsu Nhwa Pharmaceutical Competitive Strengths & Weaknesses
Table 279. Yichang Humanwell Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 280. Yichang Humanwell Pharmaceutical Major Business
Table 281. Yichang Humanwell Pharmaceutical GABA Receptor Agonists Product and Services
Table 282. Yichang Humanwell Pharmaceutical GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 283. Yichang Humanwell Pharmaceutical Recent Developments/Updates
Table 284. Yichang Humanwell Pharmaceutical Competitive Strengths & Weaknesses
Table 285. Shandong Sine Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 286. Shandong Sine Pharmaceutical Major Business
Table 287. Shandong Sine Pharmaceutical GABA Receptor Agonists Product and Services
Table 288. Shandong Sine Pharmaceutical GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 289. Shandong Sine Pharmaceutical Recent Developments/Updates
Table 290. Shandong Sine Pharmaceutical Competitive Strengths & Weaknesses
Table 291. Shanghai SPH Sine Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 292. Shanghai SPH Sine Pharmaceutical Major Business
Table 293. Shanghai SPH Sine Pharmaceutical GABA Receptor Agonists Product and Services
Table 294. Shanghai SPH Sine Pharmaceutical GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 295. Shanghai SPH Sine Pharmaceutical Recent Developments/Updates
Table 296. Shanghai SPH Sine Pharmaceutical Competitive Strengths & Weaknesses
Table 297. Global Key Players of GABA Receptor Agonists Upstream (Raw Materials)
Table 298. Global GABA Receptor Agonists Typical Customers
Table 299. GABA Receptor Agonists Typical Distributors
Table 1. World GABA Receptor Agonists Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World GABA Receptor Agonists Production Value by Region (2021-2026) & (USD Million)
Table 3. World GABA Receptor Agonists Production Value by Region (2027-2032) & (USD Million)
Table 4. World GABA Receptor Agonists Production Value Market Share by Region (2021-2026)
Table 5. World GABA Receptor Agonists Production Value Market Share by Region (2027-2032)
Table 6. World GABA Receptor Agonists Production by Region (2021-2026) & (K Dose)
Table 7. World GABA Receptor Agonists Production by Region (2027-2032) & (K Dose)
Table 8. World GABA Receptor Agonists Production Market Share by Region (2021-2026)
Table 9. World GABA Receptor Agonists Production Market Share by Region (2027-2032)
Table 10. World GABA Receptor Agonists Average Price by Region (2021-2026) & (USD/Pcs)
Table 11. World GABA Receptor Agonists Average Price by Region (2027-2032) & (USD/Pcs)
Table 12. GABA Receptor Agonists Major Market Trends
Table 13. World GABA Receptor Agonists Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World GABA Receptor Agonists Consumption by Region (2021-2026) & (K Dose)
Table 15. World GABA Receptor Agonists Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World GABA Receptor Agonists Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key GABA Receptor Agonists Producers in 2025
Table 18. World GABA Receptor Agonists Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key GABA Receptor Agonists Producers in 2025
Table 20. World GABA Receptor Agonists Average Price by Manufacturer (2021-2026) & (USD/Pcs)
Table 21. Global GABA Receptor Agonists Company Evaluation Quadrant
Table 22. World GABA Receptor Agonists Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and GABA Receptor Agonists Production Site of Key Manufacturer
Table 24. GABA Receptor Agonists Market: Company Product Type Footprint
Table 25. GABA Receptor Agonists Market: Company Product Application Footprint
Table 26. GABA Receptor Agonists Competitive Factors
Table 27. GABA Receptor Agonists New Entrant and Capacity Expansion Plans
Table 28. GABA Receptor Agonists Mergers & Acquisitions Activity
Table 29. United States VS China GABA Receptor Agonists Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China GABA Receptor Agonists Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China GABA Receptor Agonists Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based GABA Receptor Agonists Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers GABA Receptor Agonists Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers GABA Receptor Agonists Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers GABA Receptor Agonists Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers GABA Receptor Agonists Production Market Share (2021-2026)
Table 37. China Based GABA Receptor Agonists Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers GABA Receptor Agonists Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers GABA Receptor Agonists Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers GABA Receptor Agonists Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers GABA Receptor Agonists Production Market Share (2021-2026)
Table 42. Rest of World Based GABA Receptor Agonists Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers GABA Receptor Agonists Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers GABA Receptor Agonists Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers GABA Receptor Agonists Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers GABA Receptor Agonists Production Market Share (2021-2026)
Table 47. World GABA Receptor Agonists Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World GABA Receptor Agonists Production by Type (2021-2026) & (K Dose)
Table 49. World GABA Receptor Agonists Production by Type (2027-2032) & (K Dose)
Table 50. World GABA Receptor Agonists Production Value by Type (2021-2026) & (USD Million)
Table 51. World GABA Receptor Agonists Production Value by Type (2027-2032) & (USD Million)
Table 52. World GABA Receptor Agonists Average Price by Type (2021-2026) & (USD/Pcs)
Table 53. World GABA Receptor Agonists Average Price by Type (2027-2032) & (USD/Pcs)
Table 54. World GABA Receptor Agonists Production Value by Pharmacological Action Mode, (USD Million), 2021 & 2025 & 2032
Table 55. World GABA Receptor Agonists Production by Pharmacological Action Mode (2021-2026) & (K Dose)
Table 56. World GABA Receptor Agonists Production by Pharmacological Action Mode (2027-2032) & (K Dose)
Table 57. World GABA Receptor Agonists Production Value by Pharmacological Action Mode (2021-2026) & (USD Million)
Table 58. World GABA Receptor Agonists Production Value by Pharmacological Action Mode (2027-2032) & (USD Million)
Table 59. World GABA Receptor Agonists Average Price by Pharmacological Action Mode (2021-2026) & (USD/Pcs)
Table 60. World GABA Receptor Agonists Average Price by Pharmacological Action Mode (2027-2032) & (USD/Pcs)
Table 61. World GABA Receptor Agonists Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 62. World GABA Receptor Agonists Production by Dosage Form (2021-2026) & (K Dose)
Table 63. World GABA Receptor Agonists Production by Dosage Form (2027-2032) & (K Dose)
Table 64. World GABA Receptor Agonists Production Value by Dosage Form (2021-2026) & (USD Million)
Table 65. World GABA Receptor Agonists Production Value by Dosage Form (2027-2032) & (USD Million)
Table 66. World GABA Receptor Agonists Average Price by Dosage Form (2021-2026) & (USD/Pcs)
Table 67. World GABA Receptor Agonists Average Price by Dosage Form (2027-2032) & (USD/Pcs)
Table 68. World GABA Receptor Agonists Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World GABA Receptor Agonists Production by Application (2021-2026) & (K Dose)
Table 70. World GABA Receptor Agonists Production by Application (2027-2032) & (K Dose)
Table 71. World GABA Receptor Agonists Production Value by Application (2021-2026) & (USD Million)
Table 72. World GABA Receptor Agonists Production Value by Application (2027-2032) & (USD Million)
Table 73. World GABA Receptor Agonists Average Price by Application (2021-2026) & (USD/Pcs)
Table 74. World GABA Receptor Agonists Average Price by Application (2027-2032) & (USD/Pcs)
Table 75. Sanofi Basic Information, Manufacturing Base and Competitors
Table 76. Sanofi Major Business
Table 77. Sanofi GABA Receptor Agonists Product and Services
Table 78. Sanofi GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Sanofi Recent Developments/Updates
Table 80. Sanofi Competitive Strengths & Weaknesses
Table 81. Roche Basic Information, Manufacturing Base and Competitors
Table 82. Roche Major Business
Table 83. Roche GABA Receptor Agonists Product and Services
Table 84. Roche GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Roche Recent Developments/Updates
Table 86. Roche Competitive Strengths & Weaknesses
Table 87. Novartis Basic Information, Manufacturing Base and Competitors
Table 88. Novartis Major Business
Table 89. Novartis GABA Receptor Agonists Product and Services
Table 90. Novartis GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Novartis Recent Developments/Updates
Table 92. Novartis Competitive Strengths & Weaknesses
Table 93. Viatris Basic Information, Manufacturing Base and Competitors
Table 94. Viatris Major Business
Table 95. Viatris GABA Receptor Agonists Product and Services
Table 96. Viatris GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Viatris Recent Developments/Updates
Table 98. Viatris Competitive Strengths & Weaknesses
Table 99. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 100. Teva Pharmaceutical Industries Major Business
Table 101. Teva Pharmaceutical Industries GABA Receptor Agonists Product and Services
Table 102. Teva Pharmaceutical Industries GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Teva Pharmaceutical Industries Recent Developments/Updates
Table 104. Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 105. Sandoz Basic Information, Manufacturing Base and Competitors
Table 106. Sandoz Major Business
Table 107. Sandoz GABA Receptor Agonists Product and Services
Table 108. Sandoz GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Sandoz Recent Developments/Updates
Table 110. Sandoz Competitive Strengths & Weaknesses
Table 111. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 112. Lundbeck Major Business
Table 113. Lundbeck GABA Receptor Agonists Product and Services
Table 114. Lundbeck GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Lundbeck Recent Developments/Updates
Table 116. Lundbeck Competitive Strengths & Weaknesses
Table 117. Biocodex Basic Information, Manufacturing Base and Competitors
Table 118. Biocodex Major Business
Table 119. Biocodex GABA Receptor Agonists Product and Services
Table 120. Biocodex GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Biocodex Recent Developments/Updates
Table 122. Biocodex Competitive Strengths & Weaknesses
Table 123. Immedica Pharma Basic Information, Manufacturing Base and Competitors
Table 124. Immedica Pharma Major Business
Table 125. Immedica Pharma GABA Receptor Agonists Product and Services
Table 126. Immedica Pharma GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Immedica Pharma Recent Developments/Updates
Table 128. Immedica Pharma Competitive Strengths & Weaknesses
Table 129. Azurity Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 130. Azurity Pharmaceuticals Major Business
Table 131. Azurity Pharmaceuticals GABA Receptor Agonists Product and Services
Table 132. Azurity Pharmaceuticals GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Azurity Pharmaceuticals Recent Developments/Updates
Table 134. Azurity Pharmaceuticals Competitive Strengths & Weaknesses
Table 135. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 136. Amneal Pharmaceuticals Major Business
Table 137. Amneal Pharmaceuticals GABA Receptor Agonists Product and Services
Table 138. Amneal Pharmaceuticals GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Amneal Pharmaceuticals Recent Developments/Updates
Table 140. Amneal Pharmaceuticals Competitive Strengths & Weaknesses
Table 141. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 142. Fresenius Kabi Major Business
Table 143. Fresenius Kabi GABA Receptor Agonists Product and Services
Table 144. Fresenius Kabi GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Fresenius Kabi Recent Developments/Updates
Table 146. Fresenius Kabi Competitive Strengths & Weaknesses
Table 147. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 148. Hikma Pharmaceuticals Major Business
Table 149. Hikma Pharmaceuticals GABA Receptor Agonists Product and Services
Table 150. Hikma Pharmaceuticals GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Hikma Pharmaceuticals Recent Developments/Updates
Table 152. Hikma Pharmaceuticals Competitive Strengths & Weaknesses
Table 153. Eagle Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 154. Eagle Pharmaceuticals Major Business
Table 155. Eagle Pharmaceuticals GABA Receptor Agonists Product and Services
Table 156. Eagle Pharmaceuticals GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Eagle Pharmaceuticals Recent Developments/Updates
Table 158. Eagle Pharmaceuticals Competitive Strengths & Weaknesses
Table 159. PAION Pharma Basic Information, Manufacturing Base and Competitors
Table 160. PAION Pharma Major Business
Table 161. PAION Pharma GABA Receptor Agonists Product and Services
Table 162. PAION Pharma GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. PAION Pharma Recent Developments/Updates
Table 164. PAION Pharma Competitive Strengths & Weaknesses
Table 165. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 166. Mundipharma Major Business
Table 167. Mundipharma GABA Receptor Agonists Product and Services
Table 168. Mundipharma GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Mundipharma Recent Developments/Updates
Table 170. Mundipharma Competitive Strengths & Weaknesses
Table 171. Eisai Basic Information, Manufacturing Base and Competitors
Table 172. Eisai Major Business
Table 173. Eisai GABA Receptor Agonists Product and Services
Table 174. Eisai GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Eisai Recent Developments/Updates
Table 176. Eisai Competitive Strengths & Weaknesses
Table 177. Sumitomo Pharma Basic Information, Manufacturing Base and Competitors
Table 178. Sumitomo Pharma Major Business
Table 179. Sumitomo Pharma GABA Receptor Agonists Product and Services
Table 180. Sumitomo Pharma GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Sumitomo Pharma Recent Developments/Updates
Table 182. Sumitomo Pharma Competitive Strengths & Weaknesses
Table 183. ANI Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 184. ANI Pharmaceuticals Major Business
Table 185. ANI Pharmaceuticals GABA Receptor Agonists Product and Services
Table 186. ANI Pharmaceuticals GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. ANI Pharmaceuticals Recent Developments/Updates
Table 188. ANI Pharmaceuticals Competitive Strengths & Weaknesses
Table 189. Zydus Lifesciences Basic Information, Manufacturing Base and Competitors
Table 190. Zydus Lifesciences Major Business
Table 191. Zydus Lifesciences GABA Receptor Agonists Product and Services
Table 192. Zydus Lifesciences GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. Zydus Lifesciences Recent Developments/Updates
Table 194. Zydus Lifesciences Competitive Strengths & Weaknesses
Table 195. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 196. Aurobindo Pharma Major Business
Table 197. Aurobindo Pharma GABA Receptor Agonists Product and Services
Table 198. Aurobindo Pharma GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 199. Aurobindo Pharma Recent Developments/Updates
Table 200. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 201. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 202. Sun Pharmaceutical Industries Major Business
Table 203. Sun Pharmaceutical Industries GABA Receptor Agonists Product and Services
Table 204. Sun Pharmaceutical Industries GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. Sun Pharmaceutical Industries Recent Developments/Updates
Table 206. Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 207. Cipla Basic Information, Manufacturing Base and Competitors
Table 208. Cipla Major Business
Table 209. Cipla GABA Receptor Agonists Product and Services
Table 210. Cipla GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 211. Cipla Recent Developments/Updates
Table 212. Cipla Competitive Strengths & Weaknesses
Table 213. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 214. Torrent Pharmaceuticals Major Business
Table 215. Torrent Pharmaceuticals GABA Receptor Agonists Product and Services
Table 216. Torrent Pharmaceuticals GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 217. Torrent Pharmaceuticals Recent Developments/Updates
Table 218. Torrent Pharmaceuticals Competitive Strengths & Weaknesses
Table 219. Endo Basic Information, Manufacturing Base and Competitors
Table 220. Endo Major Business
Table 221. Endo GABA Receptor Agonists Product and Services
Table 222. Endo GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 223. Endo Recent Developments/Updates
Table 224. Endo Competitive Strengths & Weaknesses
Table 225. Baxter Basic Information, Manufacturing Base and Competitors
Table 226. Baxter Major Business
Table 227. Baxter GABA Receptor Agonists Product and Services
Table 228. Baxter GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 229. Baxter Recent Developments/Updates
Table 230. Baxter Competitive Strengths & Weaknesses
Table 231. Hameln Pharma Basic Information, Manufacturing Base and Competitors
Table 232. Hameln Pharma Major Business
Table 233. Hameln Pharma GABA Receptor Agonists Product and Services
Table 234. Hameln Pharma GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 235. Hameln Pharma Recent Developments/Updates
Table 236. Hameln Pharma Competitive Strengths & Weaknesses
Table 237. Ethypharm Basic Information, Manufacturing Base and Competitors
Table 238. Ethypharm Major Business
Table 239. Ethypharm GABA Receptor Agonists Product and Services
Table 240. Ethypharm GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 241. Ethypharm Recent Developments/Updates
Table 242. Ethypharm Competitive Strengths & Weaknesses
Table 243. Neuraxpharm Basic Information, Manufacturing Base and Competitors
Table 244. Neuraxpharm Major Business
Table 245. Neuraxpharm GABA Receptor Agonists Product and Services
Table 246. Neuraxpharm GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 247. Neuraxpharm Recent Developments/Updates
Table 248. Neuraxpharm Competitive Strengths & Weaknesses
Table 249. Sawai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 250. Sawai Pharmaceutical Major Business
Table 251. Sawai Pharmaceutical GABA Receptor Agonists Product and Services
Table 252. Sawai Pharmaceutical GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 253. Sawai Pharmaceutical Recent Developments/Updates
Table 254. Sawai Pharmaceutical Competitive Strengths & Weaknesses
Table 255. Towa Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 256. Towa Pharmaceutical Major Business
Table 257. Towa Pharmaceutical GABA Receptor Agonists Product and Services
Table 258. Towa Pharmaceutical GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 259. Towa Pharmaceutical Recent Developments/Updates
Table 260. Towa Pharmaceutical Competitive Strengths & Weaknesses
Table 261. Nichi-Iko Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 262. Nichi-Iko Pharmaceutical Major Business
Table 263. Nichi-Iko Pharmaceutical GABA Receptor Agonists Product and Services
Table 264. Nichi-Iko Pharmaceutical GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 265. Nichi-Iko Pharmaceutical Recent Developments/Updates
Table 266. Nichi-Iko Pharmaceutical Competitive Strengths & Weaknesses
Table 267. Zhejiang Jingxin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 268. Zhejiang Jingxin Pharmaceutical Major Business
Table 269. Zhejiang Jingxin Pharmaceutical GABA Receptor Agonists Product and Services
Table 270. Zhejiang Jingxin Pharmaceutical GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 271. Zhejiang Jingxin Pharmaceutical Recent Developments/Updates
Table 272. Zhejiang Jingxin Pharmaceutical Competitive Strengths & Weaknesses
Table 273. Jiangsu Nhwa Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 274. Jiangsu Nhwa Pharmaceutical Major Business
Table 275. Jiangsu Nhwa Pharmaceutical GABA Receptor Agonists Product and Services
Table 276. Jiangsu Nhwa Pharmaceutical GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 277. Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
Table 278. Jiangsu Nhwa Pharmaceutical Competitive Strengths & Weaknesses
Table 279. Yichang Humanwell Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 280. Yichang Humanwell Pharmaceutical Major Business
Table 281. Yichang Humanwell Pharmaceutical GABA Receptor Agonists Product and Services
Table 282. Yichang Humanwell Pharmaceutical GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 283. Yichang Humanwell Pharmaceutical Recent Developments/Updates
Table 284. Yichang Humanwell Pharmaceutical Competitive Strengths & Weaknesses
Table 285. Shandong Sine Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 286. Shandong Sine Pharmaceutical Major Business
Table 287. Shandong Sine Pharmaceutical GABA Receptor Agonists Product and Services
Table 288. Shandong Sine Pharmaceutical GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 289. Shandong Sine Pharmaceutical Recent Developments/Updates
Table 290. Shandong Sine Pharmaceutical Competitive Strengths & Weaknesses
Table 291. Shanghai SPH Sine Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 292. Shanghai SPH Sine Pharmaceutical Major Business
Table 293. Shanghai SPH Sine Pharmaceutical GABA Receptor Agonists Product and Services
Table 294. Shanghai SPH Sine Pharmaceutical GABA Receptor Agonists Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 295. Shanghai SPH Sine Pharmaceutical Recent Developments/Updates
Table 296. Shanghai SPH Sine Pharmaceutical Competitive Strengths & Weaknesses
Table 297. Global Key Players of GABA Receptor Agonists Upstream (Raw Materials)
Table 298. Global GABA Receptor Agonists Typical Customers
Table 299. GABA Receptor Agonists Typical Distributors
LIST OF FIGURES
Figure 1. GABA Receptor Agonists Picture
Figure 2. World GABA Receptor Agonists Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World GABA Receptor Agonists Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World GABA Receptor Agonists Production (2021-2032) & (K Dose)
Figure 5. World GABA Receptor Agonists Average Price (2021-2032) & (USD/Pcs)
Figure 6. World GABA Receptor Agonists Production Value Market Share by Region (2021-2032)
Figure 7. World GABA Receptor Agonists Production Market Share by Region (2021-2032)
Figure 8. North America GABA Receptor Agonists Production (2021-2032) & (K Dose)
Figure 9. Europe GABA Receptor Agonists Production (2021-2032) & (K Dose)
Figure 10. China GABA Receptor Agonists Production (2021-2032) & (K Dose)
Figure 11. Japan GABA Receptor Agonists Production (2021-2032) & (K Dose)
Figure 12. India GABA Receptor Agonists Production (2021-2032) & (K Dose)
Figure 13. South Korea GABA Receptor Agonists Production (2021-2032) & (K Dose)
Figure 14. GABA Receptor Agonists Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World GABA Receptor Agonists Consumption (2021-2032) & (K Dose)
Figure 17. World GABA Receptor Agonists Consumption Market Share by Region (2021-2032)
Figure 18. United States GABA Receptor Agonists Consumption (2021-2032) & (K Dose)
Figure 19. China GABA Receptor Agonists Consumption (2021-2032) & (K Dose)
Figure 20. Europe GABA Receptor Agonists Consumption (2021-2032) & (K Dose)
Figure 21. Japan GABA Receptor Agonists Consumption (2021-2032) & (K Dose)
Figure 22. South Korea GABA Receptor Agonists Consumption (2021-2032) & (K Dose)
Figure 23. ASEAN GABA Receptor Agonists Consumption (2021-2032) & (K Dose)
Figure 24. India GABA Receptor Agonists Consumption (2021-2032) & (K Dose)
Figure 25. Producer Shipments of GABA Receptor Agonists by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 26. Global Four-firm Concentration Ratios (CR4) for GABA Receptor Agonists Markets in 2025
Figure 27. Global Four-firm Concentration Ratios (CR8) for GABA Receptor Agonists Markets in 2025
Figure 28. United States VS China: GABA Receptor Agonists Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: GABA Receptor Agonists Production Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States VS China: GABA Receptor Agonists Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States Based Manufacturers GABA Receptor Agonists Production Market Share 2025
Figure 32. China Based Manufacturers GABA Receptor Agonists Production Market Share 2025
Figure 33. Rest of World Based Manufacturers GABA Receptor Agonists Production Market Share 2025
Figure 34. World GABA Receptor Agonists Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World GABA Receptor Agonists Production Value Market Share by Type in 2025
Figure 36. GABA_A receptor-targeted drugs
Figure 37. GABA_B receptor-targeted drugs
Figure 38. Others
Figure 39. World GABA Receptor Agonists Production Market Share by Type (2021-2032)
Figure 40. World GABA Receptor Agonists Production Value Market Share by Type (2021-2032)
Figure 41. World GABA Receptor Agonists Average Price by Type (2021-2032) & (USD/Pcs)
Figure 42. World GABA Receptor Agonists Production Value by Pharmacological Action Mode, (USD Million), 2021 & 2025 & 2032
Figure 43. World GABA Receptor Agonists Production Value Market Share by Pharmacological Action Mode in 2025
Figure 44. Direct GABA receptor agonists
Figure 45. Positive allosteric modulators
Figure 46. Others
Figure 47. World GABA Receptor Agonists Production Market Share by Pharmacological Action Mode (2021-2032)
Figure 48. World GABA Receptor Agonists Production Value Market Share by Pharmacological Action Mode (2021-2032)
Figure 49. World GABA Receptor Agonists Average Price by Pharmacological Action Mode (2021-2032) & (USD/Pcs)
Figure 50. World GABA Receptor Agonists Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 51. World GABA Receptor Agonists Production Value Market Share by Dosage Form in 2025
Figure 52. Oral dosage forms
Figure 53. Injectable dosage forms
Figure 54. Others
Figure 55. World GABA Receptor Agonists Production Market Share by Dosage Form (2021-2032)
Figure 56. World GABA Receptor Agonists Production Value Market Share by Dosage Form (2021-2032)
Figure 57. World GABA Receptor Agonists Average Price by Dosage Form (2021-2032) & (USD/Pcs)
Figure 58. World GABA Receptor Agonists Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 59. World GABA Receptor Agonists Production Value Market Share by Application in 2025
Figure 60. Attention Deficit Hyperactivity Disorder (ADHD)
Figure 61. Psychiatric Disorders and Depression
Figure 62. Alzheimer
Figure 63. Epilepsy and Seizure
Figure 64. Anxiety and Sleep Disorders
Figure 65. Obesity and Alcoholism
Figure 66. World GABA Receptor Agonists Production Market Share by Application (2021-2032)
Figure 67. World GABA Receptor Agonists Production Value Market Share by Application (2021-2032)
Figure 68. World GABA Receptor Agonists Average Price by Application (2021-2032) & (USD/Pcs)
Figure 69. GABA Receptor Agonists Industry Chain
Figure 70. GABA Receptor Agonists Procurement Model
Figure 71. GABA Receptor Agonists Sales Model
Figure 72. GABA Receptor Agonists Sales Channels, Direct Sales, and Distribution
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. GABA Receptor Agonists Picture
Figure 2. World GABA Receptor Agonists Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World GABA Receptor Agonists Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World GABA Receptor Agonists Production (2021-2032) & (K Dose)
Figure 5. World GABA Receptor Agonists Average Price (2021-2032) & (USD/Pcs)
Figure 6. World GABA Receptor Agonists Production Value Market Share by Region (2021-2032)
Figure 7. World GABA Receptor Agonists Production Market Share by Region (2021-2032)
Figure 8. North America GABA Receptor Agonists Production (2021-2032) & (K Dose)
Figure 9. Europe GABA Receptor Agonists Production (2021-2032) & (K Dose)
Figure 10. China GABA Receptor Agonists Production (2021-2032) & (K Dose)
Figure 11. Japan GABA Receptor Agonists Production (2021-2032) & (K Dose)
Figure 12. India GABA Receptor Agonists Production (2021-2032) & (K Dose)
Figure 13. South Korea GABA Receptor Agonists Production (2021-2032) & (K Dose)
Figure 14. GABA Receptor Agonists Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World GABA Receptor Agonists Consumption (2021-2032) & (K Dose)
Figure 17. World GABA Receptor Agonists Consumption Market Share by Region (2021-2032)
Figure 18. United States GABA Receptor Agonists Consumption (2021-2032) & (K Dose)
Figure 19. China GABA Receptor Agonists Consumption (2021-2032) & (K Dose)
Figure 20. Europe GABA Receptor Agonists Consumption (2021-2032) & (K Dose)
Figure 21. Japan GABA Receptor Agonists Consumption (2021-2032) & (K Dose)
Figure 22. South Korea GABA Receptor Agonists Consumption (2021-2032) & (K Dose)
Figure 23. ASEAN GABA Receptor Agonists Consumption (2021-2032) & (K Dose)
Figure 24. India GABA Receptor Agonists Consumption (2021-2032) & (K Dose)
Figure 25. Producer Shipments of GABA Receptor Agonists by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 26. Global Four-firm Concentration Ratios (CR4) for GABA Receptor Agonists Markets in 2025
Figure 27. Global Four-firm Concentration Ratios (CR8) for GABA Receptor Agonists Markets in 2025
Figure 28. United States VS China: GABA Receptor Agonists Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: GABA Receptor Agonists Production Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States VS China: GABA Receptor Agonists Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States Based Manufacturers GABA Receptor Agonists Production Market Share 2025
Figure 32. China Based Manufacturers GABA Receptor Agonists Production Market Share 2025
Figure 33. Rest of World Based Manufacturers GABA Receptor Agonists Production Market Share 2025
Figure 34. World GABA Receptor Agonists Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World GABA Receptor Agonists Production Value Market Share by Type in 2025
Figure 36. GABA_A receptor-targeted drugs
Figure 37. GABA_B receptor-targeted drugs
Figure 38. Others
Figure 39. World GABA Receptor Agonists Production Market Share by Type (2021-2032)
Figure 40. World GABA Receptor Agonists Production Value Market Share by Type (2021-2032)
Figure 41. World GABA Receptor Agonists Average Price by Type (2021-2032) & (USD/Pcs)
Figure 42. World GABA Receptor Agonists Production Value by Pharmacological Action Mode, (USD Million), 2021 & 2025 & 2032
Figure 43. World GABA Receptor Agonists Production Value Market Share by Pharmacological Action Mode in 2025
Figure 44. Direct GABA receptor agonists
Figure 45. Positive allosteric modulators
Figure 46. Others
Figure 47. World GABA Receptor Agonists Production Market Share by Pharmacological Action Mode (2021-2032)
Figure 48. World GABA Receptor Agonists Production Value Market Share by Pharmacological Action Mode (2021-2032)
Figure 49. World GABA Receptor Agonists Average Price by Pharmacological Action Mode (2021-2032) & (USD/Pcs)
Figure 50. World GABA Receptor Agonists Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 51. World GABA Receptor Agonists Production Value Market Share by Dosage Form in 2025
Figure 52. Oral dosage forms
Figure 53. Injectable dosage forms
Figure 54. Others
Figure 55. World GABA Receptor Agonists Production Market Share by Dosage Form (2021-2032)
Figure 56. World GABA Receptor Agonists Production Value Market Share by Dosage Form (2021-2032)
Figure 57. World GABA Receptor Agonists Average Price by Dosage Form (2021-2032) & (USD/Pcs)
Figure 58. World GABA Receptor Agonists Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 59. World GABA Receptor Agonists Production Value Market Share by Application in 2025
Figure 60. Attention Deficit Hyperactivity Disorder (ADHD)
Figure 61. Psychiatric Disorders and Depression
Figure 62. Alzheimer
Figure 63. Epilepsy and Seizure
Figure 64. Anxiety and Sleep Disorders
Figure 65. Obesity and Alcoholism
Figure 66. World GABA Receptor Agonists Production Market Share by Application (2021-2032)
Figure 67. World GABA Receptor Agonists Production Value Market Share by Application (2021-2032)
Figure 68. World GABA Receptor Agonists Average Price by Application (2021-2032) & (USD/Pcs)
Figure 69. GABA Receptor Agonists Industry Chain
Figure 70. GABA Receptor Agonists Procurement Model
Figure 71. GABA Receptor Agonists Sales Model
Figure 72. GABA Receptor Agonists Sales Channels, Direct Sales, and Distribution
Figure 73. Methodology
Figure 74. Research Process and Data Source
